2Sigurs N, Bjamason R, Sigurbergsson F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at abe 7[J]. An J Respit Crit Care Med, 2000, 161(5): 1501.
4Bonville C A, Rosenberg H F, Domaehowske J B. Ribavifin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis[J]. Antiviral Research, 2005, 69: 53.
5Volovitz B, Weltiver Re, De Castro G, et al. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: rolein obstructive airway disease [J]. Pediatr Res, 1988, 24: 504.
6Bisgaa.rd H. Study group on montelukast in respiratory syncytial virus postbron-ehiolitis[J]. Am J Respir Crit Care Med, 2003, 167(3): 379.
7Arnirav M D. Real-Life Effectiveness of Singulair (Montelukast) in 506 Children with Mild to Moderate Asthma[J]. IMAI, 2008, 10: 287.
8Robertson C F, Price D, Henry R, et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am[J]. Respir Crit Care Med, 2007, 175: 323.
3Pechere JC.Community acquired pneumonian children.West Sussex:Cambridge Medical Publishing House,1995.29-34.
4Weber MW,Mulholland EK,Greenwood BM.Respiratory syncytial virus infection in tropical and developing countries.Trop Med Int Health,1998,3(4):286-280.
5Sigurs N,Bjarnason R,Sigurbergsson F,et al.Asthma and immunolobin antibodies after RSV bronchiditis:a prospective cohort study with matched controls.Pediatrics,1995,95(4):500-505.
